Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer s Life and Analytical Sciences Business Posts 6-Percent Q3 Revenue Growth

NEW YORK, Oct. 26 (GenomeWeb News) - PerkinElmer's Life and Analytical Sciences business unit reported revenue of $259.1 million for the third quarter of 2005 yesterday, up 6 percent from $243.7 million in the third quarter of 2004.

 

The company attributed the growth of this business to its genetic screening, service, and environmental businesses.  

 

PerkinElmer posted total third-quarter 2005 revenue of $361.9 million, a 6 percent increase over $341.6 million in the third quarter of 2004.

 

Earlier this month, the company said it planned to divest its Fluid Sciences business in order to focus on the health science market, which was responsible for 81 percent of PerkinElmer's total revenues for the quarter.

 

PerkinElmer reported net income of $31.8 million, a 32-percent increase over $24 million in the third quarter of 2004.

 

The company reported GAAP earnings per share from continuing operations of $.20, an increase of 43 percent over GAAP earnings per share of $.14 in the prior-year period.

 

PerkinElmer spent $21.8 million on R&D during the third quarter of 2005, up slightly from $20.4 million in the comparable period of 2004.

 

As of Oct. 2, PerkinElmer had cash and cash equivalents of $166.1 million.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.